Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Bristol Myers Squibb (BMY) Nabs Diabetes Player Amylin Pharmaceuticals (AMLN). W
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Seeking Alpha...

  • "Monday, July 2, 2:06 PM Now that Amylin (AMLN) is being sold, Rodman & Renshaw's Michael King says fellow diabetes firms MannKind (MNKD +6.55%) and Vivus (VVUS +0.4%) could be acquisition targets as well. It's worth noting, though, that King's speculation accompanies a mea culpa for being wrong about Amylin, whose assets he described as "mediocre." "
  • http://seekingalpha.com/currents/post/396821
    • Reply New Message
    Prev Message Back To Forum Threaded View Next Message
    Share
    Share
    New Message
    Please login to post a reply